We last reviewed the charts of Perrigo Corp. (PRGO) on April 9, 2020. We wrote that "After dealing with a drug recall fiasco two years ago I cannot wait for drugs and supplements to be made in the U.S. again. I guess I have some skin in the game when I look at PRGO. Traders could approach the long side of PRGO at current levels, risking a close below $41. Our initial upside price target is $56."
More from Stocks
Here's a play in ETHE as we're rocked around by the swings in stocks.
Technically the market has made some positive progress with two intraday reversals in a row to the upside, but it's still a balancing act for investors.
Here's how I deal with my personal accounts in times of turmoil.
Here's my approach and how it fits into the current action.